97 related articles for article (PubMed ID: 17090516)
1. Current state of clinical and morphological features in human NCL.
Goebel HH; Wisniewski KE
Brain Pathol; 2004 Jan; 14(1):61-9. PubMed ID: 14997938
[TBL] [Abstract][Full Text] [Related]
2. Plasma biomarkers for neuronal ceroid lipofuscinosis.
Hersrud SL; Geraets RD; Weber KL; Chan CH; Pearce DA
FEBS J; 2016 Feb; 283(3):459-71. PubMed ID: 26565144
[TBL] [Abstract][Full Text] [Related]
3. Intragenic MFSD8 duplication and histopathological findings in a rabbit with neuronal ceroid lipofuscinosis.
Christen M; Gregor KM; Böttcher-Künneke A; Lombardo MS; Baumgärtner W; Jagannathan V; Puff C; Leeb T
Anim Genet; 2024 May; ():. PubMed ID: 38712841
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials in rare disease: challenges and opportunities.
Augustine EF; Adams HR; Mink JW
J Child Neurol; 2013 Sep; 28(9):1142-50. PubMed ID: 24014509
[TBL] [Abstract][Full Text] [Related]
5. Neuronal ceroid lipofuscinosis diagnosed via skin biopsy.
Puri PK; Leilani Valdes C; Angelica Selim M; Bentley RC
J Clin Neurosci; 2010 Dec; 17(12):1585-7. PubMed ID: 20800490
[TBL] [Abstract][Full Text] [Related]
6. Investigating ultrastructural morphology in MIRAGE syndrome-derived fibroblasts using transmission electron microscopy.
Buonocore F; Balys M; Anderson G; Achermann JC
F1000Res; 2023; 12():155. PubMed ID: 38434662
[TBL] [Abstract][Full Text] [Related]
7. Buffy Coat Score as a Biomarker of Treatment Response in Neuronal Ceroid Lipofuscinosis Type 2.
Sivananthan S; Lee L; Anderson G; Csanyi B; Williams R; Gissen P
Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831752
[TBL] [Abstract][Full Text] [Related]
8. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.
Mole SE; Schulz A; Badoe E; Berkovic SF; de Los Reyes EC; Dulz S; Gissen P; Guelbert N; Lourenco CM; Mason HL; Mink JW; Murphy N; Nickel M; Olaya JE; Scarpa M; Scheffer IE; Simonati A; Specchio N; Von Löbbecke I; Wang RY; Williams RE
Orphanet J Rare Dis; 2021 Apr; 16(1):185. PubMed ID: 33882967
[TBL] [Abstract][Full Text] [Related]
9. Differential accumulation of storage bodies with aging defines discrete subsets of microglia in the healthy brain.
Burns JC; Cotleur B; Walther DM; Bajrami B; Rubino SJ; Wei R; Franchimont N; Cotman SL; Ransohoff RM; Mingueneau M
Elife; 2020 Jun; 9():. PubMed ID: 32579115
[TBL] [Abstract][Full Text] [Related]
10. Substrate Reduction Therapy in Four Patients with Milder CLN1 Mutations and Juvenile-Onset Batten Disease Using Cysteamine Bitartrate.
Gavin M; Wen GY; Messing J; Adelman S; Logush A; Jenkins EC; Brown WT; Velinov M
JIMD Rep; 2013; 11():87-92. PubMed ID: 23588842
[TBL] [Abstract][Full Text] [Related]
11. Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging.
Dyke JP; Sondhi D; Voss HU; Shungu DC; Mao X; Yohay K; Worgall S; Hackett NR; Hollmann C; Yeotsas ME; Jeong AL; Van de Graaf B; Cao I; Kaminsky SM; Heier LA; Rudser KD; Souweidane MM; Kaplitt MG; Kosofsky B; Crystal RG; Ballon D
AJNR Am J Neuroradiol; 2013 Apr; 34(4):884-9. PubMed ID: 23042927
[TBL] [Abstract][Full Text] [Related]
12. Autophagy contributes to degradation of Hirano bodies.
Kim DH; Davis RC; Furukawa R; Fechheimer M
Autophagy; 2009 Jan; 5(1):44-51. PubMed ID: 18989098
[TBL] [Abstract][Full Text] [Related]
13. Batten disease in the west of Scotland 1974-1995 including five cases of the juvenile form with granular osmiophilic deposits.
Crow YJ; Tolmie JL; Howatson AG; Patrick WJ; Stephenson JB
Neuropediatrics; 1997 Jun; 28(3):140-4. PubMed ID: 9266550
[TBL] [Abstract][Full Text] [Related]
14. Fingerprint inclusions in non-vacuolated lymphocytes in juvenile neuronal ceroid-lipofuscinosis.
Goebel HH
Clin Neuropathol; 1985; 4(5):210-3. PubMed ID: 2998665
[TBL] [Abstract][Full Text] [Related]
15. [Ceroid-lipofuscinosis: ultrastructural study of 8 cases].
Matias C; Cabral A; Tasso T; Portela R; Jorge A; Nunes JF; Soares J
Acta Med Port; 1989; 2(4-5):207-14. PubMed ID: 2618809
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte inclusions in Finnish-variant late infantile neuronal ceroid lipofuscinosis (CLN5).
Rapola J; Lake BD
Neuropediatrics; 2000 Feb; 31(1):33-4. PubMed ID: 10774993
[TBL] [Abstract][Full Text] [Related]
17. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations.
Wisneiwski KE; Kida E; Patxot OF; Connell F
Am J Med Genet; 1992 Feb; 42(4):525-32. PubMed ID: 1319116
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens.
Anderson GW; Smith VV; Brooke I; Malone M; Sebire NJ
Ultrastruct Pathol; 2006; 30(5):373-8. PubMed ID: 17090516
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
